153 research outputs found
Structural Study of the Compound [(C10O8H2)2 (C4N2H6)].2H2O Synthesized by Hydrothermal Condition
A new metal–organic compound [(C10O8H2)2(C4N2H6)].2H2O(I) was hydrothermally synthesized from an aqueous solution of Fe (NO3)3 9H2O, (btec) (btec= 1, 2, 4, 5-benzenetetracarboxylic acid) and piperazine. Compound I crystallizes in the triclinic system with the P1 space group. The unit cell parameters are a = 8.271 Å, b = 8.500 Å, c = 9.660 Å, α = 87.12°, β = 89.53°, γ = 70.91°, Z= 2, V= 640.96(6) Å3 and Dx= 1.602g/cm3. The refinement converged into R= 0.047 and RW = 0.059. The structure, determined by single crystal X-ray diffraction, consists of two carboxyl group, piperazine and two molecules of water
Thermal analysis, X-ray diffraction, spectroscopy studies and magnetic properties of the new compound Tl2HAsO4.Te(OH)6
The Tl2HAsO4.Te(OH)6 (TlAsTe) compound crystallizes in the triclinic system P1 with unit cell parameters: a= 7.100(10) Å, b= 7.281(13) Å, c= 8.383(11) Å, α= 76.91(1)°, β= 87.16(1)°, γ= 66.96(2)°, Z= 2 and V= 388.19(1) Å3. This new structure can be described as a lamellar one with the atomic arrangement being built by planes of Te(OH)6 octahedra alterning with planes of arsenate tetrahedra. Raman and infrared spectra recorded at room temperature confirm the presence of As  and Te  groups and characterize the hydrogen bonds present in the crystal lattice. Differential scanning calorimerty shows the presence of three-phase transitions at 396 K, 408 K and 430 K present in the title compound. Typical thermal analyses, such as differential thermal analysis and thermogravimetry show that the decomposition of this material starts at about T= 445 K. Magnetization curve of Tl2HAsO4·Te(OH)6 substance have revealed a diamagnetic response overall temperature range studied
Characterization of Mechanically Alloyed Nanocrystalline Fe(Al): Crystallite Size and Dislocation Density
A nanostructured disordered Fe(Al) solid solution was obtained from elemental powders of Fe and Al using a high-energy ball mill. The transformations occurring in the material during milling were studied with the use of X-ray diffraction. In addition lattice microstrain, average crystallite size, dislocation density, and the lattice parameter were determined. Scanning electron microscopy (SEM) was employed to examine the morphology of the samples as a function of milling times. Thermal behaviour of the milled powders was examined by differential scanning calorimetry (DSC). The results, as well as dissimilarity between calorimetric curves of the powders after 2 and 20 h of milling, indicated the formation of a nanostructured Fe(Al) solid solution
Charge carrier localised in zero-dimensional (CH3NH3)3Bi2I9 clusters
A metal-organic hybrid perovskite (CH3NH3PbI3) with three-dimensional framework of metal-halide octahedra has been reported as a low-cost, solution-processable absorber for a thin-film solar cell with a power-conversion efficiency over 20%. Low-dimensional layered perovskites with metal halide slabs separated by the insulating organic layers are reported to show higher stability, but the efficiencies of the solar cells are limited by the confinement of excitons. In order to explore the confinement and transport of excitons in zero-dimensional metal–organic hybrid materials, a highly orientated film of (CH3NH3)3Bi2I9 with nanometre-sized core clusters of Bi2I93− surrounded by insulating CH3NH3+ was prepared via solution processing. The (CH3NH3)3Bi2I9 film shows highly anisotropic photoluminescence emission and excitation due to the large proportion of localised excitons coupled with delocalised excitons from intercluster energy transfer. The abrupt increase in photoluminescence quantum yield at excitation energy above twice band gap could indicate a quantum cutting due to the low dimensionality.Publisher PDFPeer reviewe
Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells
Challenges today concern chronic myeloid leukemia (CML) patients resistant to imatinib. There is growing evidence that imatinib-resistant leukemic cells present abnormal glucose metabolism but the impact on mitochondria has been neglected. Our work aimed to better understand and exploit the metabolic alterations of imatinib-resistant leukemic cells. Imatinib-resistant cells presented high glycolysis as compared to sensitive cells. Consistently, expression of key glycolytic enzymes, at least partly mediated by HIF-1α, was modified in imatinib-resistant cells suggesting that imatinib-resistant cells uncouple glycolytic flux from pyruvate oxidation. Interestingly, mitochondria of imatinib-resistant cells exhibited accumulation of TCA cycle intermediates, increased NADH and low oxygen consumption. These mitochondrial alterations due to the partial failure of ETC were further confirmed in leukemic cells isolated from some imatinib-resistant CML patients. As a consequence, mitochondria generated more ROS than those of imatinib-sensitive cells. This, in turn, resulted in increased death of imatinib-resistant leukemic cells following in vitro or in vivo treatment with the pro-oxidants, PEITC and Trisenox, in a syngeneic mouse tumor model. Conversely, inhibition of glycolysis caused derepression of respiration leading to lower cellular ROS. In conclusion, these findings indicate that imatinib-resistant leukemic cells have an unexpected mitochondrial dysfunction that could be exploited for selective therapeutic intervention
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
Background Biomarkers that can predict the prognosis of colorectal cancer (CRC) patients and that can stratify high-risk early stage patients from low-risk early stage patients are urgently needed for better management of CRC. During the last decades, a large variety of prognostic DNA methylation markers has been published in the literature. However, to date, none of these markers are used in clinical practice. Methods To obtain an overview of the number of published prognostic methylation markers for CRC, the number of markers that was validated independently, and the current level of evidence (LoE), we conducted a systematic review of PubMed, EMBASE, and MEDLINE. In addition, we scored studies based on the REMARK guidelines that were established in order to attain more transparency and complete reporting of prognostic biomarker studies. Eighty-three studies reporting on 123 methylation markers fulfilled the study entry criteria and were scored according to REMARK. Results Sixty-three studies investigated single methylation markers, whereas 20 studies reported combinations of methylation markers. We observed substantial variation regarding the reporting of sample sizes and patient characteristics, statistical analyses, and methodology. The median (range) REMARK score for the studies was 10.7 points (4.5 to 17.5) out of a maximum of 20 possible points. The median REMARK score was lower in studies, which reported a p value below 0.05 versus those, which did not (p = 0.005). A borderline statistically significant association was observed between the reported p value of the survival analysis and the size of the study population (p = 0.051). Only 23 out of 123 markers (17%) were investigated in two or more study series. For 12 markers, and two multimarker panels, consistent results were reported in two or more study series. For four markers, the current LoE is level II, for all other markers, the LoE is lower. Conclusion This systematic review reflects that adequate reporting according to REMARK and validation of prognostic methylation markers is absent in the majority of CRC methylation marker studies. However, this systematic review provides a comprehensive overview of published prognostic methylation markers for CRC and highlights the most promising markers that have been published in the last two decades
Nonlinear Dynamics Analysis of FGM Shell Structures with a Higher Order Shear Strain Enhanced Solid-Shell Element
Progress on lead-free metal halide perovskites for photovoltaic applications: a review
ABSTRACT: Metal halide perovskites have revolutionized the field of solution-processable photovoltaics. Within just a few years, the power conversion efficiencies of perovskite-based solar cells have been improved significantly to over 20%, which makes them now already comparably efficient to silicon-based photovoltaics. This breakthrough in solution-based photovoltaics, however, has the drawback that these high efficiencies can only be obtained with lead-based perovskites and this will arguably be a substantial hurdle for various applications of perovskite-based photovoltaics and their acceptance in society, even though the amounts of lead in the solar cells are low. This fact opened up a new research field on lead-free metal halide perovskites, which is currently remarkably vivid. We took this as incentive to review this emerging research field and discuss possible alternative elements to replace lead in metal halide perovskites and the properties of the corresponding perovskite materials based on recent theoretical and experimental studies. Up to now, tin-based perovskites turned out to be most promising in terms of power conversion efficiency; however, also the toxicity of these tin-based perovskites is argued. In the focus of the research community are other elements as well including germanium, copper, antimony, or bismuth, and the corresponding perovskite compounds are already showing promising properties. GRAPHICAL ABSTRACT: [Image: see text
Synthesis, Calorimetric and X ray diffraction studies in the solid solution Tl2(SO4)1−X(SeO4)X.Te(OH)6 0≤X≤1
- …